Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ghisa

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Gastroenterology|April 30, 2020
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging DataElisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort StudyBrigida Barberio, Fabiana Zingone, Renata D'Incà, et al.
Journal of Clinical Medicine|July 2, 2020
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 OutbreakEdoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, et al.
Expert Review of Gastroenterology & Hepatology|September 22, 2021
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disordersVincenzo Savarino, Luca Antonioli, Matteo Fornai, et al.
Neurogastroenterology and Motility|October 2, 2019
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallowsBenjamin D Rogers, Arvind Rengarajan, Aurelio Mauro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2022
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical TrialsPierfrancesco Visaggi, Matteo Ghisa, Brigida Barberio, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2022
Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjectsSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Therapeutic Advances in Gastroenterology|April 5, 2021
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patientsSonia Facchin, Andrea Buda, Romilda Cardin, et al.
Expert Opinion on Pharmacotherapy|November 6, 2024
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adultsElisa Marabotto, Francesco Calabrese, Andrea Pasta, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Gastroenterology|April 30, 2020
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging DataElisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort StudyBrigida Barberio, Fabiana Zingone, Renata D'Incà, et al.
Journal of Clinical Medicine|July 2, 2020
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 OutbreakEdoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, et al.
Expert Review of Gastroenterology & Hepatology|September 22, 2021
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disordersVincenzo Savarino, Luca Antonioli, Matteo Fornai, et al.
Neurogastroenterology and Motility|October 2, 2019
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallowsBenjamin D Rogers, Arvind Rengarajan, Aurelio Mauro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2022
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical TrialsPierfrancesco Visaggi, Matteo Ghisa, Brigida Barberio, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2022
Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjectsSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Therapeutic Advances in Gastroenterology|April 5, 2021
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patientsSonia Facchin, Andrea Buda, Romilda Cardin, et al.
Expert Opinion on Pharmacotherapy|November 6, 2024
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adultsElisa Marabotto, Francesco Calabrese, Andrea Pasta, et al.
Pageof 10